Interleukin-6 Antagonist class drugs
1 result
Sylvant (siltuximab)
(Siltuximab)EUSA Pharma (UK) Ltd
Usage: SYLVANT is indicated for treating multicentric Castleman's disease in patients who are HIV negative and HHV-8 negative. It has not been studied in HIV or HHV-8 positive patients due to its inability to bind to virally produced IL-6.